Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML).

Strategies that augment a GVL effect without increasing the risk of GVHD are required to improve the outcome after allogeneic stem cell transplantation (SCT). Azacitidine (AZA) up-regulates the expression of tumor Ags on leukemic blasts in vitro and expands the numbers of immunomodulatory T regulato...

Full description

Bibliographic Details
Main Authors:	Goodyear, O, Dennis, M, Jilani, N, Loke, J, Siddique, S, Ryan, G, Nunnick, J, Khanum, R, Raghavan, M, Cook, M, Snowden, J, Griffiths, M, Russell, N, Yin, J, Crawley, C, Cook, G, Vyas, P, Moss, P, Malladi, R, Craddock, C
Format:	Journal article
Language:	English
Published:	2012

Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML).

Similar Items